Dr. Wood is Chief of IR and founding Director of the NIH Center for Interventional Oncology that develops and translates novel devices, software, and navigation approaches for cancer patients within a multi-disciplinary framework. Biomedical engineering is applied to unmet clinical needs via novel local and regional minimally-invasive image-guided therapies. His team's achievements include helping to pioneer technologies from concept to bench to patient, including “first-in-human” for the following:

kidney, adrenal and pheochromocytoma cancer ablation; prostate cancer MRI/TRUS fusion biopsy and ablation; image-able iodinated drug eluting beads for chemoembolization; heat-deployed nanoparticle chemotherapy with thermal ablation for cancer; electromagnetic tracking for fusion of ultrasound to CT, MR, and PET; and fusion for biopsy and ablation. The NCI CCR liver cancer team (with CCR's Tim Greten) was also the first in clinical trials to combine check point immunotherapies with local and regional image-guided thermal ablation or chemo-embolization for liver and biliary tract cancers.

Metrics include > 50 patents, books on Radiology & Interventional Urology, > 600 publications (H-index of 112) including JAMA, NEJM, Nature Medicine, Nature Comm, Science, Lancet,  Cancer, Science Transl Med, JNCI, JAMA Oncology, Hepatology, & Medical Physics. The team's research relies upon multi-disciplinary international public-private partnerships, and the team has mentored hundreds of students, fellows, physicians, nurses, and scientists.

Teamwork and team science breed success.